Singapore-based Quadria Capital, through an affiliated entity, has entered into a definitive agreement for the sale of 100% of its interest in FV Hospital to Thomson Medical Group for a total consideration of up to $381.4 million, marking the country’s biggest healthcare transaction to-date and Southeast Asia’s largest healthcare acquisition since 2020.

Quadria Capital invested in FV in 2017 with the vision to transform the hospital into a leading multidisciplinary tertiary care provider in Vietnam. Over the years, Quadria has supported the hospital in expanding its reach, developing new specialties, and attracting top talent to provide world-class treatments to over 250,000 patients annually.

Today, with 1,600 full-time staff comprising over 200 doctors, FV Group provides patients with an extensive clinical offering across 36 medical specialties.

Through Quadria’s partnership, FV has developed several leading Centres of Excellence in specialties such as Oncology, Cardiology, Gastroenterology and Ophthalmology among others.

FV’s Hy Vong Cancer Centre, one of the most advanced cancer centres in Southeast Asia, underwent an upgrade in 2018, which equipped the centre with a state-of-the-art Linear Accelerator, CT simulations, and the latest generation of spectrophotometer systems, facilitating access to the most advanced treatment plans.

A strategic partnership with HealthCare Global Enterprises (HCG), the largest oncology provider in India, has enabled FV to further enhance its use of therapeutic technology and provide training to doctors, nurses and technicians, which has significantly improved clinical outcomes. Since 2018, the Hy Vong centre has provided treatment to over 35,000 cancer patients.